ADHD and methylphenidate tied to higher adult BMI
Seoul National University Hospital researchers have linked childhood attention-deficit/hyperactivity disorder and methylphenidate exposure with higher adult overweight/obesity and slightly shorter adult height at ages 20 to 25 years.
Read MoreFDA Accepts NDA for Priority Review: Centanafadine for Treatment of ADHD
Key Takeaways: Centanafadine, a first-in-class NDSRI, shows promise for ADHD treatment across varied age groups, with significant symptom improvement in phase 3 trials. The drug demonstrated a favorable safety profile, with common adverse events being decreased appetite, nausea, and headache, and low abuse potential. Recent studies indicate centanafadine’s potential in addressing emotional dysregulation and executive…
Read MoreLimited evidence elimination diet resolves ADHD symptoms
Research shows that eating nutritious meals helps the brain function optimally, but numerous social media posts are claiming that avoiding gluten, dairy, corn and soy can eradicate symptoms of attention deficit hyperactivity disorder (ADHD). Experts said these claims are not backed by robust research, cautioning against strict elimination diets for children.
Read MoreNature Outlook: ADHD
The quest to understand and treat a pervasive and mystifying mental health condition.
Read MoreYour Wedding Doesn’t Have to Be Long, Loud or Uncomfortable
Weddings can be challenging for those with neurodivergence. As awareness grows, vendors are creating sensory-friendly solutions.
Read MoreUse of ADHD medication in UK more than tripled in 13 years, study finds
UK had highest relative increase of five countries in study, with 20-fold rise in proportion of women over 25 using it
Read MoreHow students with ADHD experience autonomy in learning
[Excerpt] Along with psychologist and researcher Audhild Løhre, Uthus conducted an interview study focusing on two school children: “Sofie” and “Benjamin.” Both students have ADHD. The researchers followed the pupils and their teachers over the course of one school year during which their school introduced a new model for adapted education. Both pupils describe how…
Read MoreA Patient’s Journey: From Stuttering to Advocacy—and What Psychiatrists Need to Know
From APSARD 2026, a patient journey demonstrates opportunities in psychiatric education on stuttering and emerging treatment approaches.
Read MoreNew ADHD Medications Discussed at APSARD 2026
Tim Wilens, MD, discussed mechanism of action and efficacy of new medications at APSARD Conference.
Read MoreA New Lens on Pharmacotherapy for ADHD in Pregnancy
Clinicians explore the complex relationship between ADHD medication and pregnancy, emphasizing individualized risk assessments for optimal maternal and child health.
Read MoreAdult Age at Diagnosis May Represent a Less Severe Phenotype Than Childhood Diagnosis
Adults who receive an ADHD diagnosis later in life may represent a somewhat less severe clinical subtype than those diagnosed in youth, but still experience impairment that warrants clinical attention, according to new data presented at American Professional Society of ADHD and Related Disorders (APSARD) 2026 Annual Conference.1,2
Read MoreCognitively Engaging Exercises Improve Sustained Attention in Children With ADHD
Key point: Compared with standard aerobic exercise, cognitively engaging exercise programs improved sustained attention of children and adolescents with ADHD, with multiple longer sessions having a more significant effect.
Read More